通策医疗 (600763.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

31.4x

EV/EBITDA

19.0x

Market Cap

CNY 15.48B

MomentumView details →

1D Return

−2.15%

YTD Return

−11.69%

RSI (14)

49.6

ValuationView details →

P/E (Fwd)

31.4x

EV/EBITDA

19.0x

Market Cap

CNY 15.48B

RSI (14)

49.6

MomentumView details →

1D Return

−2.15%

YTD Return

−11.69%

ProfitabilityView details →

Gross Margin

38.56%

Net Margin

17.27%

EBITDA Margin

29.55%

ROE (TTM)

11.42%

ROA (TTM)

8.09%

Asset Turnover

0.48x

GrowthView details →

Revenue YoY

+0.48%

EPS YoY

−0.69%

FCF YoY

+14.15%

Revenue CAGR 3Y

+2.33%

EPS CAGR 3Y

−13.16%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.58

EPS Surprise

94.49%

Beats (12Q)

1/12

Next Q EPS Est

CNY 0.45

Avg Surprise (4Q)

94.49%

Rev Surprise

−0.78%

Capital & dividendView details →

Debt/Equity

0.23x

Current Ratio

1.71x

Quick Ratio

1.68x

Div Yield

—

Div Rate

—

Div Growth 1Y

+3.29%

Financials snapshotView financials →

Revenue (TTM)

2.92B

Net Income (TTM)

504.99M

Op. CF (TTM)

824.10M

Next earningsOct 28, 2026 →

Latest newsMore news →

Tongce Medical announced its 2026 first-half results, with net profit attributable to shareholders of 458 million yuan, up 32.70% year-on-year.21d ago

Similar companies

Solventum CorporationSOLV Fresenius Medical Care AG & Co. KGaAFMS Encompass Health CorporationEHC DaVita Inc.DVA Tenet Healthcare CorporationTHC Universal Health Services, Inc.UHS Find similar companies →

Latest newsMore news →

Tongce Medical announced its 2026 first-half results, with net profit attributable to shareholders of 458 million yuan, up 32.70% year-on-year.21d ago